Prostate Cancer Biomarker Market Report

Global and Region Prostate Cancer Biomarker Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：141
  • REPORT CODE：GMM964526
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Prostate Cancer Biomarker market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Prostate Cancer Biomarkermarket, defines the market attractiveness level of Prostate Cancer Biomarker market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Prostate Cancer Biomarker industry, describes the types of Prostate Cancer Biomarker market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prostate Cancer Biomarker market and the development prospects and opportunities of Prostate Cancer Biomarker industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prostate Cancer Biomarker market in Chapter 13.

    By Player:

    • QIAGEN

    • Sanofi-Aventis

    • Beckman Coulter

    • MDx Health

    • Myriad Genetics

    • Pfizer

    • Thermo Fisher Scientific

    • Roche Diagnostics

    By Type:

    • Urine

    • Blood

    • Serum

    By End-User:

    • Hospitals

    • Clinics

    • Cancer Institutes

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Prostate Cancer Biomarker Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Prostate Cancer Biomarker Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Prostate Cancer Biomarker Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Prostate Cancer Biomarker Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Prostate Cancer Biomarker Market Analysis and Outlook to 2022

    • 7.1 Global Prostate Cancer Biomarker Consumption (2017-2022)

    • 7.2 United States Prostate Cancer Biomarker Consumption (2017-2022)

    • 7.3 Europe Prostate Cancer Biomarker Consumption (2017-2022)

    • 7.4 China Prostate Cancer Biomarker Consumption (2017-2022)

    • 7.5 Japan Prostate Cancer Biomarker Consumption (2017-2022)

    • 7.6 India Prostate Cancer Biomarker Consumption (2017-2022)

    • 7.7 South Korea Prostate Cancer Biomarker Consumption (2017-2022)

    8 Region and Country-wise Prostate Cancer Biomarker Market Analysis and Outlook to 2028

    • 8.1 Global Prostate Cancer Biomarker Consumption Forecast (2022-2028)

    • 8.2 United States Prostate Cancer Biomarker Consumption Forecast (2022-2028)

    • 8.3 Europe Prostate Cancer Biomarker Consumption Forecast (2022-2028)

    • 8.4 China Prostate Cancer Biomarker Consumption Forecast (2022-2028)

    • 8.5 Japan Prostate Cancer Biomarker Consumption Forecast (2022-2028)

    • 8.6 India Prostate Cancer Biomarker Consumption Forecast (2022-2028)

    • 8.7 South Korea Prostate Cancer Biomarker Consumption Forecast (2022-2028)

    9 Global Prostate Cancer Biomarker Market Outlook by Types and Applications to 2022

    • 9.1 Global Prostate Cancer Biomarker Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Urine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Blood Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Serum Consumption and Growth Rate (2017-2022)

    • 9.2 Global Prostate Cancer Biomarker Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cancer Institutes Consumption and Growth Rate (2017-2022)

    10 Global Prostate Cancer Biomarker Market Outlook by Types and Applications to 2028

    • 10.1 Global Prostate Cancer Biomarker Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Urine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Blood Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Serum Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Prostate Cancer Biomarker Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cancer Institutes Consumption Forecast and Growth Rate (2022-2028)

    11 Global Prostate Cancer Biomarker Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Prostate Cancer Biomarker Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Prostate Cancer Biomarker Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Prostate Cancer Biomarker Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Prostate Cancer Biomarker Market Competitive Analysis

    • 14.1 QIAGEN

      • 14.1.1 QIAGEN Company Details

      • 14.1.2 QIAGEN Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 QIAGEN Prostate Cancer Biomarker Product and Service

    • 14.2 Sanofi-Aventis

      • 14.2.1 Sanofi-Aventis Company Details

      • 14.2.2 Sanofi-Aventis Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sanofi-Aventis Prostate Cancer Biomarker Product and Service

    • 14.3 Beckman Coulter

      • 14.3.1 Beckman Coulter Company Details

      • 14.3.2 Beckman Coulter Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Beckman Coulter Prostate Cancer Biomarker Product and Service

    • 14.4 MDx Health

      • 14.4.1 MDx Health Company Details

      • 14.4.2 MDx Health Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 MDx Health Prostate Cancer Biomarker Product and Service

    • 14.5 Myriad Genetics

      • 14.5.1 Myriad Genetics Company Details

      • 14.5.2 Myriad Genetics Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Myriad Genetics Prostate Cancer Biomarker Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Prostate Cancer Biomarker Product and Service

    • 14.7 Thermo Fisher Scientific

      • 14.7.1 Thermo Fisher Scientific Company Details

      • 14.7.2 Thermo Fisher Scientific Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Thermo Fisher Scientific Prostate Cancer Biomarker Product and Service

    • 14.8 Roche Diagnostics

      • 14.8.1 Roche Diagnostics Company Details

      • 14.8.2 Roche Diagnostics Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Roche Diagnostics Prostate Cancer Biomarker Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Prostate Cancer Biomarker

    • Figure Prostate Cancer Biomarker Picture

    • Table Global Prostate Cancer Biomarker Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Prostate Cancer Biomarker Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Prostate Cancer Biomarker Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Prostate Cancer Biomarker Consumption by Country (2017-2022)

    • Figure United States Prostate Cancer Biomarker Consumption and Growth Rate (2017-2022)

    • Table Europe Prostate Cancer Biomarker Consumption and Growth Rate (2017-2022)

    • Figure China Prostate Cancer Biomarker Consumption and Growth Rate (2017-2022)

    • Figure Japan Prostate Cancer Biomarker Consumption and Growth Rate (2017-2022)

    • Figure India Prostate Cancer Biomarker Consumption and Growth Rate (2017-2022)

    • Figure South Korea Prostate Cancer Biomarker Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Biomarker Consumption Forecast by Country (2022-2028)

    • Figure United States Prostate Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Prostate Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Prostate Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Prostate Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Prostate Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Prostate Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Urine Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Consumption and Growth Rate (2017-2022)

    • Figure Global Serum Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Urine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Serum Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Prostate Cancer Biomarker Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Prostate Cancer Biomarker Export by Region (Top 5 Countries) (2017-2028)

    • Table QIAGEN (Foundation Year, Company Profile and etc.)

    • Table QIAGEN Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN Prostate Cancer Biomarker Product and Service

    • Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi-Aventis Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis Prostate Cancer Biomarker Product and Service

    • Table Beckman Coulter (Foundation Year, Company Profile and etc.)

    • Table Beckman Coulter Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beckman Coulter Prostate Cancer Biomarker Product and Service

    • Table MDx Health (Foundation Year, Company Profile and etc.)

    • Table MDx Health Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

    • Table MDx Health Prostate Cancer Biomarker Product and Service

    • Table Myriad Genetics (Foundation Year, Company Profile and etc.)

    • Table Myriad Genetics Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad Genetics Prostate Cancer Biomarker Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Prostate Cancer Biomarker Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Prostate Cancer Biomarker Product and Service

    • Table Roche Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Roche Diagnostics Prostate Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Diagnostics Prostate Cancer Biomarker Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US